Allgens(688613)2025-01-24 10:15Financial Performance - The company expects to achieve an operating revenue of 205.61 million yuan for the year 2024, with a net profit attributable to the parent company of -17.56 million yuan, indicating a loss [3]. - The projected net profit attributable to the parent company, after deducting non-recurring gains and losses, is -33.50 million yuan, a decrease of 230% compared to the previous year's net profit of 25.77 million yuan [3]. - The previous year's net profit attributable to the parent company was 54.23 million yuan, indicating a decline of 71.78 million yuan year-on-year [4]. Factors Affecting Performance - The decline in performance is attributed to a combination of factors including a decrease in unit ex-factory prices despite increased product sales volume, leading to reduced sales revenue [6]. - The company acquired HumanTech Dental in Germany to expand its dental implant business, which increased sales personnel and marketing expenses [6]. - The extension of credit terms to distributors has resulted in an increase in accounts receivable aging over one year, contributing to higher credit impairment losses [6]. - The company faced increased tax burdens due to tax payments made in 2024, further impacting overall costs and expenses [6]. Financial Reporting and Caution - The financial data provided in the performance forecast has not been audited by a registered accountant and is based on preliminary calculations by the company's finance department [7]. - Investors are advised to be cautious as the forecast data is subject to change and the final audited financial results will be disclosed in the 2024 annual report [8]. - The company emphasizes that there are no significant uncertainties affecting the accuracy of this performance forecast as of the announcement date [7].